Plasma Bioengineering Myths
Greg Fridman discusses common myths in plasma bioengineering. He addresses oversimplifications in research and development, focusing on topics like dose-response and scaling challenges.
Greg Fridman discusses common myths in plasma bioengineering. He addresses oversimplifications in research and development, focusing on topics like dose-response and scaling challenges.